Mark Stenhouse - Director at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
PHAT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Stenhouse since 11 Jan 2025

Holdings reported by Mark Stenhouse for Phathom Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30,000 $99,300 $3.31 03 Jun 2025 Direct
Stock Option (Right to Buy) 17,500 03 Jun 2025 Direct Common Stock

Transactions reported by Mark Stenhouse for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.